SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-000191
Filing Date
2021-01-05
Accepted
2021-01-04 18:22:55
Documents
13
Period of Report
2020-12-31
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bdsx-8k_20201231.htm   iXBRL 8-K 39517
2 EX-99.1 bdsx-ex991_42.htm EX-99.1 9756
  Complete submission text file 0001564590-21-000191.txt   188013

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bdsx-20201231.xsd EX-101.SCH 5760
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdsx-20201231_lab.xml EX-101.LAB 20218
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdsx-20201231_pre.xml EX-101.PRE 12072
6 EXTRACTED XBRL INSTANCE DOCUMENT bdsx-8k_20201231_htm.xml XML 3685
Mailing Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301
Business Address 2970 WILDERNESS PLACE SUITE 100 BOULDER CO 80301 303-417-0500
BIODESIX INC (Filer) CIK: 0001439725 (see all company filings)

IRS No.: 203986492 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39659 | Film No.: 21503211
SIC: 8071 Services-Medical Laboratories
Office of Life Sciences